144 related articles for article (PubMed ID: 30617674)
1. Bacterial Ghosts Carrying 5-Fluorouracil: A Novel Biological Carrier for Targeting Colorectal Cancer.
Youssof AME; Alanazi FK; Salem-Bekhit MM; Shakeel F; Haq N
AAPS PharmSciTech; 2019 Jan; 20(2):48. PubMed ID: 30617674
[TBL] [Abstract][Full Text] [Related]
2. Vision of bacterial ghosts as drug carriers mandates accepting the effect of cell membrane on drug loading.
Alanazi FK; Alsuwyeh AA; Haq N; Salem-Bekhit MM; Al-Dhfyan A; Shakeel F
Drug Dev Ind Pharm; 2020 Oct; 46(10):1716-1725. PubMed ID: 32893682
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Designing 5-Fluorouracil Delivery Systems: A Stepping Stone in the Safe Treatment of Colorectal Cancer.
Entezar-Almahdi E; Mohammadi-Samani S; Tayebi L; Farjadian F
Int J Nanomedicine; 2020; 15():5445-5458. PubMed ID: 32801699
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma.
Vilaça N; Amorim R; Machado AF; Parpot P; Pereira MF; Sardo M; Rocha J; Fonseca AM; Neves IC; Baltazar F
Colloids Surf B Biointerfaces; 2013 Dec; 112():237-44. PubMed ID: 23988779
[TBL] [Abstract][Full Text] [Related]
5. The Potential Anticancer Activity of 5-Fluorouracil Loaded in Cellulose Fibers Isolated from Rice Straw.
Yusefi M; Shameli K; Jahangirian H; Teow SY; Umakoshi H; Saleh B; Rafiee-Moghaddam R; Webster TJ
Int J Nanomedicine; 2020; 15():5417-5432. PubMed ID: 32801697
[TBL] [Abstract][Full Text] [Related]
6. Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design.
Li Y; Li X; Guan Q; Zhang C; Xu T; Dong Y; Bai X; Zhang W
Int J Nanomedicine; 2017; 12():1465-1474. PubMed ID: 28260892
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
[TBL] [Abstract][Full Text] [Related]
8. Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer.
Radu IC; Hudita A; Zaharia C; Galateanu B; Iovu H; Tanasa EV; Georgiana Nitu S; Ginghina O; Negrei C; Tsatsakis A; Velonia K; Shtilman M; Costache M
Drug Deliv; 2019 Dec; 26(1):318-327. PubMed ID: 30896267
[TBL] [Abstract][Full Text] [Related]
9. Oxidation and pH responsive nanoparticles based on ferrocene-modified chitosan oligosaccharide for 5-fluorouracil delivery.
Xu Y; Wang L; Li YK; Wang CQ
Carbohydr Polym; 2014 Dec; 114():27-35. PubMed ID: 25263860
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Microsphere Formulation for Colon Targeted Delivery of 5-Fluorouracil Using Biocompatible Natural Gum Katira.
Karan S; Choudhury H; Chakra BK; Chatterjee TK
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2181-2194. PubMed ID: 31350983
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
12. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
Ahmad MZ; Akhter S; Anwar M; Ahmad FJ
Mol Pharm; 2012 Nov; 9(11):2986-94. PubMed ID: 22994847
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
[TBL] [Abstract][Full Text] [Related]
14. Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells.
Safwat MA; Soliman GM; Sayed D; Attia MA
Int J Pharm; 2016 Nov; 513(1-2):648-658. PubMed ID: 27693737
[TBL] [Abstract][Full Text] [Related]
15. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Kumar RV; Sinha VR
Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
[TBL] [Abstract][Full Text] [Related]
16. The application of poly (glycerol-sebacate) as biodegradable drug carrier.
Sun ZJ; Chen C; Sun MZ; Ai CH; Lu XL; Zheng YF; Yang BF; Dong DL
Biomaterials; 2009 Oct; 30(28):5209-14. PubMed ID: 19560817
[TBL] [Abstract][Full Text] [Related]
17. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
[TBL] [Abstract][Full Text] [Related]
18. Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells.
Kudela P; Koller VJ; Mayr UB; Nepp J; Lubitz W; Barisani-Asenbauer T
J Biotechnol; 2011 May; 153(3-4):167-75. PubMed ID: 21501636
[TBL] [Abstract][Full Text] [Related]
19. Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells.
Paukner S; Kohl G; Lubitz W
J Control Release; 2004 Jan; 94(1):63-74. PubMed ID: 14684272
[TBL] [Abstract][Full Text] [Related]
20. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
Mishra BJ; Kaul A; Trivedi P
Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
